CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Krishnan Krish S President and CEO | Sale | −1,186 | $81.41 | $97K | 1,741,885 |
| 2023-01-17 | Krishnan Krish S President and CEO | Sale | −346 | $82.71 | $29K | 1,741,539 |
| 2023-01-17 | Krishnan Krish S President and CEO | Sale | −20,617 | $80.70 | $1.7M | 1,681,646 |
| 2023-01-17 | Krishnan Krish S President and CEO | Sale | −1,186 | $81.41 | $97K | 1,680,460 |
| 2023-01-17 | Krishnan Krish S President and CEO | Sale | −345 | $82.72 | $29K | 1,680,115 |
| 2023-01-04 | Krishnan Suma President, R&D | Sale | −3,938 | $80.09 | $315K | 1,702,263 |
| 2023-01-04 | Krishnan Suma President, R&D | Sale | −3,748 | $80.08 | $300K | 1,763,688 |
| 2023-01-04 | Krishnan Krish S President and CEO | Sale | −3,748 | $80.08 | $300K | 1,763,688 |
| 2023-01-04 | Krishnan Krish S President and CEO | Sale | −3,938 | $80.09 | $315K | 1,702,263 |
| 2023-01-03 | Krishnan Suma President, R&D | Sale | −1,700 | $80.33 | $137K | 1,706,201 |
| 2023-01-03 | Krishnan Suma President, R&D | Sale | −1,700 | $80.33 | $137K | 1,767,436 |
| 2023-01-03 | Krishnan Krish S President and CEO | Sale | −1,700 | $80.33 | $137K | 1,767,436 |
| 2023-01-03 | Krishnan Krish S President and CEO | Sale | −1,700 | $80.33 | $137K | 1,706,201 |
| 2022-12-29 | Krishnan Suma President, R&D | Sale | −7,484 | $80.30 | $601K | 1,708,429 |
| 2022-12-29 | Krishnan Suma President, R&D | Sale | −528 | $81.10 | $43K | 1,707,901 |
| 2022-12-29 | Krishnan Suma President, R&D | Sale | −7,447 | $80.28 | $598K | 1,769,699 |
| 2022-12-29 | Krishnan Suma President, R&D | Sale | −563 | $81.11 | $46K | 1,769,136 |
| 2022-12-29 | Krishnan Krish S President and CEO | Sale | −7,447 | $80.28 | $598K | 1,769,699 |
| 2022-12-29 | Krishnan Krish S President and CEO | Sale | −563 | $81.11 | $46K | 1,769,136 |
| 2022-12-29 | Krishnan Krish S President and CEO | Sale | −7,484 | $80.30 | $601K | 1,708,429 |
Page 34 of 42 · 828 trades